Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children.
about
Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.Simultaneous determination of piperaquine and its N-oxidated metabolite in rat plasma using LC-MS/MS.Frequent Malaria Drives Progressive Vδ2 T-Cell Loss, Dysfunction, and CD16 Up-regulation During Early Childhood.Effective Antimalarial Chemoprevention in Childhood Enhances the Quality of CD4+ T Cells and Limits Their Production of Immunoregulatory Interleukin 10.Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trialSickle Cell Disease Clinical Trials and Phenotypes
P2860
Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Variable piperaquine exposure ...... f malaria in Ugandan children.
@ast
Variable piperaquine exposure ...... f malaria in Ugandan children.
@en
type
label
Variable piperaquine exposure ...... f malaria in Ugandan children.
@ast
Variable piperaquine exposure ...... f malaria in Ugandan children.
@en
prefLabel
Variable piperaquine exposure ...... f malaria in Ugandan children.
@ast
Variable piperaquine exposure ...... f malaria in Ugandan children.
@en
P2093
P2860
P921
P1433
P1476
Variable piperaquine exposure ...... f malaria in Ugandan children.
@en
P2093
Francesca Aweeka
James Kapisi
Kerstin Sundell
Liusheng Huang
Mary M Kakuru
Prasanna Jagannathan
Rada Savic
Victor Bigira
P2860
P2888
P356
10.1186/S12936-015-0908-8
P577
2015-09-24T00:00:00Z
P5875
P6179
1007776979